@sigtrans-sttt.bsky.socialThe phase 3 ANCHOR trial finds that anlotinib + CapeOX shows similar antitumor activity to bevacizumab + CapeOX in RAS/BRAF wild-type #Metastatic #ColorectalCancer, but does not meet the prespecified noninferiority margin for PFS.
@doublewhammied.bsky.socialGr8 debate at the #ILCSymposium as 2 whethr #chemo is helpful or not in #metastatic CLASSICAL #lobular #breastcancer. Dr. Rebecca Shatsky argues chemo failed 3 tests in #mILC: it's not superior, not durable, not biologically matched. Chemo shld be exception, not default. @lobularbca.bsky.social
@doublewhammied.bsky.socialFirst up this morning, @fredhutch.org's translational researcher Dr. Kevin Cheung talking about the #metastatic "interactome" in #lobular #breastcancer #CanSky #ILCSymposium #bcsm @lobularbca.bsky.social @elbcc-2018.bsky.social @lobularbcuk.bsky.social
@talius2.bsky.social#New #combination #therapy shows promise in #metastatic #pancreatic #cancer
Results from an early-stage clinical trial shows a 4-drug therapy has broken through metastatic pancreatic cancer's defenses, rendering one patient completely cancer-free >> scitechupdates.com/n...
